MTOR and type 2 diabetes mellitus: DMY could activate the AMPK/mTOR signaling pathway, trigger autophagy and act as the antagonism for high glucose-induced oxidative damage of endothelial cells, making it be a hopeful drug for the treatment of T2DM.